Enzyme's movement may be key to new cancer drugs - Science Daily
Enzyme's movement may be key to new cancer drugs Science Daily
To watch a kinase called mitogen-activated protein kinase (MAPK) p38 in action, the researchers used nuclear magnetic resonance (NMR) spectroscopy. All necessary molecules had to bind to p38 for the enzyme to become active. Only then could the ...
Enzyme's movement may be key to new cancer drugs - Science Daily More...
Did you find this post helpful? |
Similar Threads
Thread
Thread Starter
Forum
Replies
Last Post
Interfering with enzyme's movement may be new approach for developing of anti-cancer drugs - News-Medical.net
http://www.bionmr.com//t2.gstatic.com/images?q=tbn:ANd9GcR8JLyCl_TBn74dosW54RiWq5k6RI16xRp7_Wl1EZxjE6GeQlHlSBgXMZWOd0Zi-Qp8mh6JAYmY
News-Medical.net
<img alt="" height="1" width="1">
Interfering with enzyme's movement may be new approach for developing of anti-cancer drugs
News-Medical.net
To watch a kinase called mitogen-activated protein kinase (MAPK) p38 in action, the researchers used nuclear magnetic resonance (NMR) spectroscopy. All necessary molecules had to bind to p38 for the enzyme to become active. Only then could the ...
Interfering with enzyme's movement may be new...
nmrlearner
Online News
0
05-16-2018 03:42 PM
Enzyme's Movement May Be Key to New Cancer Drugs - UANews (press release)
http://www.bionmr.com//t2.gstatic.com/images?q=tbn:ANd9GcRU5ps9B_AsxWZutYNhbyuT0iN6r4CcMTrYGFNoboImA6hS0X4DCbMdeGnZUmDxRuSxqCaImqyS
UANews (press release)
<img alt="" height="1" width="1">
Enzyme's Movement May Be Key to New Cancer Drugs
UANews (press release)
To watch a kinase called mitogen-activated protein kinase (MAPK) p38 in action, the researchers used nuclear magnetic resonance (NMR) spectroscopy. All necessary molecules had to bind to p38 for the enzyme to become active. Only then could the ...
Enzyme's Movement May Be Key to New Cancer Drugs - UANews (press release)
nmrlearner
Online News
0
05-16-2018 03:41 AM
Enzyme's movement may be key to new cancer drugs - EurekAlert (press release)
http://www.bionmr.com//t1.gstatic.com/images?q=tbn:ANd9GcTsNtH9YpxxAQ6ksPtPSZU0Z09vvbZhDQEOKHaJ3v7FZ4YWTEIyvhvW3H5toO9Rh1H0x8fgcCvA
EurekAlert (press release)
<img alt="" height="1" width="1">
Enzyme's movement may be key to new cancer drugs
EurekAlert (press release)
To watch a kinase called mitogen-activated protein kinase (MAPK) p38 in action, the researchers used nuclear magnetic resonance (NMR) spectroscopy. All necessary molecules had to bind to p38 for the enzyme to become active. Only then could the ...
Enzyme's movement may be key to new cancer drugs - EurekAlert (press...
nmrlearner
Online News
0
05-15-2018 03:38 PM
[NMR paper] Reconstitution of Low-Density Lipoproteins with Fatty Acids for the Targeted Delivery of Drugs into Cancer Cells
Reconstitution of Low-Density Lipoproteins with Fatty Acids for the Targeted Delivery of Drugs into Cancer Cells
Low-density lipoproteins (LDLs) are a class of nanocarriers for the targeted delivery of therapeutics into aberrant cells that overexpress the LDL receptor. A facile procedure is used for reconstituting the hydrophobic core of LDLs with a binary fatty acid mixture. Facilitated by the tumor targeting capability of the apolipoprotein, the reconstituted, drug-loaded LDLs can effectively target cancer cells that overexpress the LDL receptor while showing minor adverse impact on...
nmrlearner
Journal club
0
07-24-2017 10:10 AM
[NMR paper] Reconstitution of Low-Density Lipoproteins with Fatty Acids for the Targeted Delivery of Drugs into Cancer Cells
Reconstitution of Low-Density Lipoproteins with Fatty Acids for the Targeted Delivery of Drugs into Cancer Cells
Low-density lipoproteins (LDLs) represent a novel class of nanocarriers for the targeted delivery of therapeutics into aberrant cells that overexpress the LDL receptor. Here we report a facile procedure for reconstituting the hydrophobic core of LDLs with a binary fatty acid mixture. Facilitated by the tumor targeting capability of the apolipoprotein, the reconstituted, drug-loaded LDLs can effectively target cancer cells that overexpress the LDL receptor while showing minor...
nmrlearner
Journal club
0
06-24-2017 08:20 PM
The good, the bad and the spliceosome - Science Daily
<img alt="" height="1" width="1">
The good, the bad and the spliceosome
Science Daily
"By employing nuclear magnetic resonance (NMR) spectroscopy at the Bavarian NMR Center in Garching, we were able to elucidate the spatial structure of RBM5-OCRE in complex with SmN (a protein present in the spliceosome) and to understand exactly ...
The good, the bad and the spliceosome - Science Daily
More...
nmrlearner
Online News
0
11-29-2016 09:02 PM
Novel protein inhibitors engineered as alternative approach to potentially treat cancer - Science Daily
http://www.bionmr.com//t1.gstatic.com/images?q=tbn:ANd9GcTArx6QDkt_eys4vsBX6AKLFWNV35-5QEwADhFv6KBkEJhgPFqbiubXiOnuko403fIt--H0YDcs
Science Daily
<img alt="" height="1" width="1">
Novel protein inhibitors engineered as alternative approach to potentially treat cancer
Science Daily
Superimposed ribbon structures of N-TIMP-1 extracted from 3D structures of complexes with different MMPs determined by X-ray crystallography, and two structures of the free protein in solution determined by nuclear magnetic resonance spectroscopy.
Novel protein inhibitors engineered as alternative...
nmrlearner
Online News
0
06-07-2016 02:39 PM
Study reveals insights into protein linked to cancer, Alzheimer's disease - Science Daily
Study reveals insights into protein linked to cancer, Alzheimer's disease - Science Daily
<img alt="" height="1" width="1">
Study reveals insights into protein linked to cancer, Alzheimer's disease
Science Daily
NMR-based model for Pin1 (â??Aâ?? and â??Bâ?? globular domains), and its interaction with its â??disorderedâ?? protein targets pertinent to cancer and Alzheimer's disease (green). The Pin1 â??Aâ?? and â??Bâ?? domains specialize in peptidyl-prolyl isomerase activity and ...
Read here